Strides Pharma Science Ltd
NSE:STAR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Strides Pharma Science Ltd
Total Other Income
Strides Pharma Science Ltd
Total Other Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Strides Pharma Science Ltd
NSE:STAR
|
Total Other Income
₹1.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
23%
|
CAGR 10-Years
10%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Total Other Income
₹13.6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
37%
|
CAGR 10-Years
21%
|
|
|
Cipla Ltd
NSE:CIPLA
|
Total Other Income
₹10.2B
|
CAGR 3-Years
36%
|
CAGR 5-Years
28%
|
CAGR 10-Years
17%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Total Other Income
₹21.3B
|
CAGR 3-Years
78%
|
CAGR 5-Years
21%
|
CAGR 10-Years
8%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Total Other Income
₹3.4B
|
CAGR 3-Years
85%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Total Other Income
-₹947.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Strides Pharma Science Ltd
Glance View
Strides Pharma Science Ltd. engages in the development, manufacture and distribution of Internet Protocol-led generics and bio-pharmaceutical products. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2000-02-03. The firm is focused on development and manufacture of IP-led niche and pharmaceutical products. The company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The firm manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as, liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. The company has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). The company is also engaged in manufacturing soft gelatin capsules. The company develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
See Also
What is Strides Pharma Science Ltd's Total Other Income?
Total Other Income
1.5B
INR
Based on the financial report for Dec 31, 2025, Strides Pharma Science Ltd's Total Other Income amounts to 1.5B INR.
What is Strides Pharma Science Ltd's Total Other Income growth rate?
Total Other Income CAGR 10Y
10%
Over the last year, the Total Other Income growth was 366%. The average annual Total Other Income growth rates for Strides Pharma Science Ltd have been 1% over the past three years , 23% over the past five years , and 10% over the past ten years .
